US Medical Devices Ishares ETF (IHI)

While Zimmer Biomet has lagged behind the broader market over the past year, analysts continue to hold a moderately positive view on the stock's prospects.

Edwards Lifesciences has underperformed the broader market over the past year, but analysts are moderately optimistic about the stock’s prospects.

Medtech giant Stryker has outperformed the broader market over the past year, and analysts remain moderately bullish on the stock’s prospects.

Medtronic has lagged behind the broader market over the past year, and analysts remain cautiously bullish on the stock’s prospects.

Boston Scientific has significantly outperformed the broader market over the past year, and analysts maintain a very bullish view on its outlook.

Boston Scientific shows impressive growth in Q3 results, garnering bullish analyst support despite clinical trial setbacks.

Abbott is all set to release its third-quarter earnings later this month, and analysts expect a single-digit profit increase.

ETFs can be safe yet powerful investments. But there are still risks involved.

While Edwards Lifesciences has underperformed the broader medical devices industry recently, analysts are moderately bullish on the stock's prospects.

IDEXX Laboratories underperformed the broader healthcare sector, but Wall Street analysts remain moderately optimistic about the stock’s prospects.